NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹142 Cr | ₹213 Cr | ₹296 Cr | ₹126 Cr | ₹249 Cr |
What is the latest Total Non-Current Liabilities ratio of NECTAR LIFESCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹142 Cr |
Mar2023 | ₹213 Cr |
Mar2022 | ₹296 Cr |
Mar2021 | ₹126 Cr |
Mar2020 | ₹249 Cr |
How is Total Non-Current Liabilities of NECTAR LIFESCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹142 Cr | -33.60 | |
Mar2023 | ₹213 Cr | -28.07 | |
Mar2022 | ₹296 Cr | 134.39 | |
Mar2021 | ₹126 Cr | -49.29 | |
Mar2020 | ₹249 Cr | - |
Compare Total Non-Current Liabilities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹447.0 Cr | -14% | -16.4% | -37.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | -14% |
-16.4% |
-37.1% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses